YOUNG JAMES EMMETT (Chief Financial Officer) purchased 25.0% of their position (6K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $33.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/6/2025ACC: 0001415889-25-003293
Officer· Chief Financial Officer
Since Jan 2025
+6K
Net shares
Net buyer
$33.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+6K
Price / share
$5.65
Trade value
$33.90K
% of position
25.0%
2/5/2025
24K→30K
Total
Net shares
+6K
Net value
$33.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/5/2025 | P · Purchase | +6K | $5.65 | $33.90K | 25.0% | 24K | 30K |
| Total | +6K | $33.90K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned21.73K
Total
21.73K direct21.73K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 21.73K | Direct |
| Total | 21.73K | 21.73K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported